Case 23: Pseudoresponse in Glioblastoma

Ian Law; Jonathan F. Carlsen; Benedikte Hasselbalch

doi:10.1007/978-3-030-83598-9_23

Case 23: Pseudoresponse in Glioblastoma

Ian Law, Jonathan F. Carlsen, Benedikte Hasselbalch

Abstract

One limitation of response assessment in glioma using conventional MRI is its reliance on the measurement of contrast enhancement reflecting a disrupted blood–brain barrier. This signal may be normalized by antiangiogenic therapy, known as pseudoresponse. Amino acid PET tracers offer a more sensitive method to identify viable glioma tissue.

Original language	Danish
Title of host publication	Clinical Nuclear Medicine in Neurology : An Atlas of Challenging Cases
Editors	Andrea Varrone, Silvia Morbelli, Valentina Garibotto
Number of pages	3
Place of Publication	Cham
Publisher	Springer International Publishing
Publication date	2022
Pages	115-117
ISBN (Print)	978-3-030-83598-9
DOIs	https://doi.org/10.1007/978-3-030-83598-9_23
Publication status	Published - 2022

Access to Document

10.1007/978-3-030-83598-9_23

Cite this

Case 23: Pseudoresponse in Glioblastoma. / Law, Ian ; Carlsen, Jonathan F.; Hasselbalch, Benedikte.
Clinical Nuclear Medicine in Neurology: An Atlas of Challenging Cases. ed. / Andrea Varrone; Silvia Morbelli; Valentina Garibotto. Cham: Springer International Publishing, 2022. p. 115-117.

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review

@inbook{955c33be5abe44c48f0eb7be75c10c52,

title = "Case 23: Pseudoresponse in Glioblastoma",

abstract = "One limitation of response assessment in glioma using conventional MRI is its reliance on the measurement of contrast enhancement reflecting a disrupted blood–brain barrier. This signal may be normalized by antiangiogenic therapy, known as pseudoresponse. Amino acid PET tracers offer a more sensitive method to identify viable glioma tissue.",

author = "Ian Law and Carlsen, {Jonathan F.} and Benedikte Hasselbalch",

year = "2022",

doi = "10.1007/978-3-030-83598-9_23",

language = "Dansk",

isbn = "978-3-030-83598-9",

pages = "115--117",

editor = "Andrea Varrone and Silvia Morbelli and Valentina Garibotto",

booktitle = "Clinical Nuclear Medicine in Neurology",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Case 23: Pseudoresponse in Glioblastoma

AU - Law, Ian

AU - Carlsen, Jonathan F.

AU - Hasselbalch, Benedikte

PY - 2022

Y1 - 2022

N2 - One limitation of response assessment in glioma using conventional MRI is its reliance on the measurement of contrast enhancement reflecting a disrupted blood–brain barrier. This signal may be normalized by antiangiogenic therapy, known as pseudoresponse. Amino acid PET tracers offer a more sensitive method to identify viable glioma tissue.

AB - One limitation of response assessment in glioma using conventional MRI is its reliance on the measurement of contrast enhancement reflecting a disrupted blood–brain barrier. This signal may be normalized by antiangiogenic therapy, known as pseudoresponse. Amino acid PET tracers offer a more sensitive method to identify viable glioma tissue.

UR - http://www.scopus.com/inward/record.url?scp=85171010159&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-83598-9_23

DO - 10.1007/978-3-030-83598-9_23

M3 - Bidrag til bog/antologi

SN - 978-3-030-83598-9

SP - 115

EP - 117

BT - Clinical Nuclear Medicine in Neurology

A2 - Varrone, Andrea

A2 - Morbelli, Silvia

A2 - Garibotto, Valentina

PB - Springer International Publishing

CY - Cham

ER -

Case 23: Pseudoresponse in Glioblastoma

Abstract

Access to Document

Other files and links

Cite this